Multiple Sclerosis Journal - Experimental, Translational and Clinical : Impact Factor & More
eISSN: 2055-2173pISSN: 2055-2173
Open AccessShare this on:
Key Metrics
CiteScore 
3.3
SJR
Q4Neurology (clinical)
SNIP
0.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Multiple Sclerosis Journal - Experimental, Translational and Clinical
Multiple Sclerosis Journal - Experimental, Translational and Clinical Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS INC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Multiple Sclerosis Journal - Experimental, Translational and Clinical
Reinitiating ocrelizumab with a full 600\u2005mg dose after extended treatment interruption: No increased risk of infusion-related reactions
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Myelin damage in radiologically isolated syndrome is associated with decreased processing speed
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain
- 13 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Men's health research priorities in men with multiple sclerosis
- 9 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Neuromyelitis optica spectrum disorder in Germany: A claims data analysis of incidence, prevalence, treatment patterns, and diagnostic overlap with multiple sclerosis
- 7 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers
- 6 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Reinitiating ocrelizumab with a full 600\u2005mg dose after extended treatment interruption: No increased risk of infusion-related reactions
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Myelin damage in radiologically isolated syndrome is associated with decreased processing speed
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain
- 13 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Men's health research priorities in men with multiple sclerosis
- 9 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Neuromyelitis optica spectrum disorder in Germany: A claims data analysis of incidence, prevalence, treatment patterns, and diagnostic overlap with multiple sclerosis
- 7 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers
- 6 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
FAQs on Multiple Sclerosis Journal - Experimental, Translational and Clinical
How long has Multiple Sclerosis Journal - Experimental, Translational and Clinical been actively publishing? 
What is the publishing frequency of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
How many articles did Multiple Sclerosis Journal - Experimental, Translational and Clinical publish last year?
What is the eISSN & pISSN for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is Citescore for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is SNIP score for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is the SJR for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Who is the publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
